Surgery


Showing 141-160 of 207 Results

  • Rahim Nazerali, MD, MHS, FACS

    Rahim Nazerali, MD, MHS, FACS

    Clinical Associate Professor, Surgery - Plastic & Reconstructive Surgery

    BioDr. Nazerali specializes in complex reconstruction, microsurgery, and aesthetic and cosmetic surgery. He excels at breast reconstruction using free autologous tissue and performs advanced techniques such as the minimally invasive superficial inferior epigastric artery (SIEA) flap, as well as the deep inferior epigastric artery perforator (DIEP) flap procedure. In addition to autologous reconstruction, Dr. Nazerali utilizes the latest techniques in implant-based breast reconstruction. His techniques and results have made him a leading instructor and lecturer at national and international institutions, societies and conferences.

    In addition to breast reconstruction, Dr. Nazerali performs both aesthetic as well as whole body reconstructive procedures. He has a busy aesthetic practice focusing on breast augmentation, face and body rejuvenation as well as body contouring. In his reconstructive practice, he specializes in abdominal wall reconstruction as well as post-trauma tissue transfers. For every patient in his care, his goal is to optimize restoration of both form and function.

    To help advance the field of plastic and reconstructive surgery, Dr. Nazerali conducts research into outcomes of breast reconstruction, augmentation, and reduction. Dr. Nazerali has published widely: well over 100 journal articles and conference proceedings. Topics include breast reconstruction after radiation; advances in surgical technique; and, the use of virtual, augmented, and mixed reality systems in plastic surgery practice and education. His work has appeared in Annals of Plastic Surgery, Plastic and Reconstructive Surgery, Surgery, the European Journal of Plastic Surgery, the Aesthetic Surgery Journal, and elsewhere.

    Dr. Nazerali focuses not only on improving his patient’s lives but also our ability to deliver care as an institution. He is on the Medical Executive Council at Stanford Healthcare, serves as a committee member in the American Society of Plastic Surgeons as well as the California Society of Plastic Surgeons. In his spare time, he volunteers his time to provide reconstructive surgical services to adults and children in need worldwide.

  • Dung Nguyen

    Dung Nguyen

    Clinical Professor, Surgery - Plastic & Reconstructive Surgery

    BioDr. Dung H Nguyen is currently the Director of Breast Reconstruction at the Stanford Women’s Cancer Center, Director of Microsurgery and Microsurgery Fellowship, and the Director of Adult Plastics Clinic at Stanford Healthcare. She graduated with a Bachelor of Science in Biochemistry and highest academic honor and distinction from U.C. Davis. She earned a Pharm.D degree from U.C.S.F. School of Pharmacy and a MD degree from U.C.S.D. She then did a residency in general surgery and a residency in Plastic and Reconstructive Surgery at the University of Southern California (USC) Medical Center. She further completed a fellowship in microsurgery from Chang Gung Memorial Hospital in Taiwan, one of the largest reconstructive surgery centers in the world. She was recruited to Stanford from Cedar Sinai Medical Center in 2012, and is currently a Clinical Professor in the Division of Plastic and Reconstructive Surgery at Stanford University.

    Dr. Nguyen specializes in aesthetic and reconstructive breast surgery, surgical treatment of lymphedema including vascularized lymph node transfer and lymphaticovenous anastomosis, and complex tissue reconstruction utilizing microsurgery and supermicrosurgery. She also has interest in cosmetic surgery, including facial rejuvenation and body contouring procedures.

    In addition to her clinical commitment, Dr. Nguyen has basic science and clinical research interests in lymphedema and breast reconstruction. She has published articles in peer review journals, presented at national and international professional meetings and has authored book chapters in various plastic surgery textbooks. She also enjoys volunteering on overseas medical missions and participating in medical charity activities.

  • Jeffrey Norton, MD

    Jeffrey Norton, MD

    Robert L. and Mary Ellenburg Professor of Surgery, Emeritus

    Current Research and Scholarly InterestsInterleukin-12 is a Th1 cytokine. It is important in the cell mediated immune response. We are investigating its role as an anti-tumor cytokine to augment the immune response against cancer. We are planning a human trial.

  • Eric Brian Pillado

    Eric Brian Pillado

    Clinical Assistant Professor, Surgery - Vascular Surgery

    BioDr. Pillado earned his bachelor’s degree at the University of Michigan before completing his medical degree at the University of California, Los Angeles. He then completed his vascular surgery residency at Northwestern University, where he also obtained a Master of Science in Health Services and Outcomes Research as well as a Master of Business Administration from the Kellogg School of Management during his professional development time.

    His clinical research interests include improving vascular surgery healthcare delivery systems in underserved patient populations, multidisciplinary limb salvage, and advancing wellness initiatives within vascular surgery training.

  • George A. Poultsides, MD, MS

    George A. Poultsides, MD, MS

    Stanford Department of Surgery Professor

    Current Research and Scholarly InterestsClinical trials of experimental diagnostics and therapeutics; outcomes analysis following combined modality treatment of hepatic, pancreatic, and gastrointestinal malignancies.

  • Janey S.A. Pratt, MD

    Janey S.A. Pratt, MD

    Clinical Professor, Surgery - Pediatric Surgery

    BioDr. Janey S.A. Pratt, MD, FACS, FASMBS is a general surgeon who specializes in Laparoscopic and Robotic General and Metabolic and Bariatric Surgery (MBS). She began her career in general surgery at Massachusetts General Hospital, where she was a founding member of the MGH Weight Center. As surgical director she introduced minimally invasive MBS and adolescent MBS to MGH in 2001 and 2007 respectively. In 2011 Dr. Pratt took over as Director at the MGH Weight Center and continued to work on several national committees towards improving access and care for adolescents with severe obesity. Dr. Pratt continued to practice general surgery throughout her tenure at MGH seeing patients with breast cancer, hernias, and obesity. She performed advance minimally invasive surgery (MIS) as well as advanced endoscopy.

    In 2016 Dr. Pratt moved to California where she began her work at Stanford University, splitting her time between the Lucille Packard Children’s Hospital and the Palo Alto VA. She performs Minimally Invasive MBS as well as endoscopy. Dr. Pratt has trained in robotic surgery as well. As a Clinical Professor of Surgery, Dr. Pratt is involved in training Stanford medical students and residents both in the OR, in clinic, in simulation labs and in the classroom. Since 2023 Dr. Pratt is dedicated only to the Children's Hospital running the Adolescent Metabolic and Bariatric Surgery program at LPCH. This is an MBSAQIP accredited program in a free-standing children's hospital dedicated to the multidisciplinary care of children with obesity. This program is one of the top 5 programs in the country. Dr. Pratt has been involved in creating and updated guidelines for Adolescent MBS since 2005. In 2018 she was first author on the ASMBS Pediatric Metabolic and Bariatric Surgery Guidelines. Her research interests include MIS MBS, pediatric obesity treatment and the use of medications to improve outcomes of MBS. Dr. Pratt frequently lectures on the subject of Adolescent Metabolic and Bariatric Surgery.

  • Carla Pugh, MD, PhD

    Carla Pugh, MD, PhD

    Thomas Krummel Professor

    Current Research and Scholarly InterestsThe Technology Enabled Clinical Improvement (T.E.C.I.) Center is a multidisciplinary team of researchers dedicated to the design and implementation of advanced engineering technologies that facilitate data acquisition relating to clinical performance.

  • Benjamin Micah Raber

    Benjamin Micah Raber

    Clinical Assistant Professor, Surgery - General Surgery

    BioDr. Benjamin Raber is a board-certified, fellowship-trained surgical oncologist at Stanford Health Care. He is also a clinical assistant professor in the Department of Surgery, Division of General Surgery at Stanford University School of Medicine.

    Dr. Raber specializes in surgical treatments for benign and cancerous breast diseases. He performs a wide range of procedures, including lumpectomy, nipple-sparing mastectomy, and preventive mastectomy. Dr. Raber uses the latest and most effective surgical approaches, including wire-free, breast-conserving surgery for lumpectomies and hidden scar surgery (to hide incisions). He is committed to compassionate, patient-centered care that involves close collaboration with his colleagues in medical and radiation oncology, radiology, and plastic surgery.

    Dr. Raber is actively involved in community outreach and breast cancer education. He has led regional initiatives to promote awareness, expand access to breast cancer screenings, and improve early detection.

    Dr. Raber’s research focuses on improving surgical treatments for breast cancer, including better ways to treat cancer that has spread to nearby lymph nodes. He has also explored using ultrasound imaging to help surgeons locate and remove cancerous tissue more precisely during breast-conserving surgery. His research has been published in prominent peer-reviewed journals, including Annals of Surgical Oncology, Magnetic Resonance Imaging Clinics of North America, and The American Journal of Surgery.

    Dr. Raber is a fellow of the American College of Surgeons (ACS) and a member of the American Society of Breast Surgeons (ASBrS).

  • Gary K. Roberts, D.D.S.

    Gary K. Roberts, D.D.S.

    Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery

    BioDr. Roberts has performed hospital dentistry and surgery at Stanford University Medical Center and Lucile Packard Children's Hospital since 1995. He is also on the faculty at University of the Pacific School of Dentistry. He treats a variety of oral and maxillofacial conditions, including dental trauma and infection, dental implant and restorative reconstruction, surgical tooth extraction, bone and tissue grafting, conventional and surgical endodontic procedures, dental oncology care of cancer patients, as well as orofacial pain treatment.

    He has presented CME lectures and Grand Rounds to numerous Departments at Stanford, as well as teaching Residents and Fellows at Stanford Medical School and the Palo Alto VA. He also lectures in the Physician Assistant Program at Stanford.

    During his nearly a quarter of a century of military service, he was one of the leading researchers on combat trauma and the pathophysiology of projectile wounds. He currently serves as a member of the Council on Peer with the California Dental Association and is an Anesthesia Evaluator for the California State Dental Board.  Dr. Roberts is frequently asked to speak on a variety of topics to organizations both in the US and internationally.

  • Brian Ruhle, MD, MS

    Brian Ruhle, MD, MS

    Clinical Assistant Professor, Surgery - General Surgery

    BioDr. Brian Ruhle is a board-certified surgeon with dual-fellowship training in minimally invasive bariatric (weight loss) surgery and endocrine surgery. He is also a clinical assistant professor in the Department of Surgery, Division of General Surgery at Stanford University School of Medicine.

    Dr. Ruhle specializes in bariatric surgery, foregut (upper digestive tract) surgery, adrenal surgery, and abdominal wall reconstruction. He uses leading-edge laparoscopic and robotic surgical techniques to help patients achieve sustainable weight loss and improve obesity-related health conditions. His expertise in advanced minimally invasive procedures offers patients significant benefits, including faster recoveries, reduced pain, and shorter hospital stays.

    Dr. Ruhle’s research interests span a wide range of topics in metabolic and bariatric surgery. His studies have explored combination therapies for managing obesity, improvements in screening and treating endocrine disorders, and optimizing outcomes in thyroid and parathyroid surgeries. He has published his findings in many peer-reviewed journals, including Surgery, Journal of Gastrointestinal Surgery, and Journal of the American College of Surgeons.

    Dr. Ruhle has presented at prominent national conferences, including the annual meetings of the American Association of Endocrine Surgeons and the American College of Surgeons Clinical Congress. His presentations have discussed using GLP-1 receptor agonists (weight loss medications that help regulate blood sugar and reduce appetite) before and after bariatric surgery. He has also addressed improving screening protocols for hyperaldosteronism (high blood pressure caused by excess production of the hormone aldosterone by the adrenal gland).

    Dr. Ruhle is a member of the American Association of Endocrine Surgeons, the American Society for Metabolic and Bariatric Surgery, and the Society of American Gastrointestinal and Endoscopic Surgeons.

  • Nazish Sayed MD, PhD

    Nazish Sayed MD, PhD

    Associate Professor (Research) of Surgery (Vascular Surgery)

    Current Research and Scholarly InterestsThe Sayed Laboratory is focused on the development of novel technologies that drive innovation in regenerative medicine, disease modeling, and drug testing in vascular biology. The lab conducts translational research in vascular biology and aims to understand the role of the vasculature in the development of cardiac diseases, including those due to inherited genetic variants or environmental insults such as type 2 diabetes or hypertension. The lab employs the human induced pluripotent stem cell (iPSC) technology to generate patient-specific vascular cells (endothelial and vascular smooth muscle cells) as an alternative to animal models providing a human tissue surrogate for research that is scalable and sustainable. By employing this unique platform, the lab also investigates the role of chemotherapeutic agents (anti-cancer drugs) on the vasculature. Dr. Sayed’s lab has also established an endothelial regeneration program, where they leverage the innate immune system to regenerate endothelial cells from human fibroblasts.

    Work from the lab has led to seminal discoveries in the areas of 1) Nitric oxide (NO) biology, (2) vascular biology, (3) stem cell biology, (4) cardiovascular disease modeling (5) cardio-oncology.